Several studies have shown elevated levels of LEF-1 in human cancers, in particular in chronic lymphatic leukemia (CLL) [58] and a very recent study describes an alteration in LEF-1 mRNA and protein expression in a wide cohort of DLBCLs [59]. This evidence concerns the gene LEF1 and B-cell chronic lymphocytic leukemia.